Splicebio Raises Eur 50M In Oversubscribed Series A Financing To Advance Protein Splicing Platform And Expand Gene Therapy Pipeline
Amount Raised
€50 Million
Round Type
Series A
BarcelonaBiotechnologySoftwareScience And EngineeringDescription
SpliceBio, a biotechnology company exploiting protein splicing to develop next generation gene therapies, today announced the completion of an oversubscribed €50 million series A financing. The financing was co-led by UCB Ventures and existing shareholder Ysios Capital and joined by new investors New Enterprise Associates (NEA), Gilde Healthcare, Novartis Venture Fund, and existing shareholder Asabys Partners. The Company was seeded in 2020 by Ysios Capital and Asabys Partners.
Quick answer
SpliceBio raised €50 Million in a Series A round, dated February 16, 2022. SpliceBio is based in Barcelona, Catalonia, Spain.
- How much did SpliceBio raise?
- SpliceBio raised €50 Million in a Series A round on February 16, 2022.
- What does SpliceBio do?
- SpliceBio is a biotechnology company exploiting Protein Splicing to develop the next generation of gene therapies.
- Where is SpliceBio based and how big is it?
- SpliceBio is based in Barcelona, Catalonia, Spain.
- Who are the decision-makers at SpliceBio?
- Fundz holds 1 contact at SpliceBio, including the Chief Medical Officer. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Science And Engineering and Biotechnology around the same time
Companies in the same sectors as SpliceBio that raised within 45 days of this round, from Fundz verified event records.
- Zephyr AI, Inc. raised $19M (Seed) on March 30, 2022.
- Nucleai raised $33M (Series B) on March 22, 2022.
- Classiq raised $33M (Funding Round) on February 17, 2022.
- Koneksa Health raised $45M (Series C) on February 7, 2022.
- Kula Bio raised $50M on January 28, 2022.
- Kula Bio raised $50M (Series A) on January 27, 2022.
Who to call at SpliceBio, and when
A new round usually means SpliceBio is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day SpliceBio raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at SpliceBio, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at SpliceBio. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment SpliceBio raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Funding Insights
What this usually meansSpliceBio raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.